BioDot, Inc
Brian Farber has over 30 years of work experience in the field of service and support management. Brian currently serves as the Sr. Director of Global Support at BioDot, Inc, where they are responsible for developing and executing the global service and support strategy. Prior to this, they held the position of Director of Global Service, Molecular Imaging at Bruker Biospin, where they developed the global service strategy for the Molecular Imaging Division. Brian also worked at BioDot as the World Wide Service Manager, where they managed the service team and developed the organization's service structure. Before that, they served as the Western Regional Service Manager at Caliper Life Sciences, where they were responsible for revenue growth and customer relationship management. Brian started their career at Instrumentation Laboratory as a Field Service Engineer and later held various roles including Western Regional Service Manager and National Service Marketing Manager. Throughout their career, Brian has effectively collaborated with cross-functional teams, implemented strategic plans, and maintained strong relationships with customers and employees.
Brian Farber has a Bachelor of Science (BS) degree in Business Administration and Management, General from Colorado State University. Brian also has an Associate of Science (AS) degree in Electrical and Electronics Engineering from ITT Technical Institute-San Diego. In addition to their degrees, they also hold a Six Sigma Green Belt certification from Carestream Health.
This person is not in any teams
This person is not in any offices
BioDot, Inc
For over 25 years, BioDot has developed proprietary, quantitative technologies for the dispensing of low volumes of fluids (picoliter to microliter) that meet the needs of industrial, life science, diagnostic, and medical products. BioDot is division of ATS Automation - Life Sciences Division On March 24, 1994, BioDot established itself as a company in Southern California with its patented BioJet™, "Drop on Demand", non-contact, dispensing technology. At that time, BioDot focused on using this technology to dispense discrete drops, or a series of drops to form a line. This quantitative, enabling technology was used predominantly in Lateral Flow Test or Flow Through Test applications in the diagnostic marketplace. Over the following years, BioDot expanded its expertise outside of dispensing, and developed lamination and cutting technologies. In parallel, it expanded its application abilities to enable scientists to utilize the quantitative dispensing and develop more sophisticated point of care tests, such as: - Glucose or other Microfluidic Sensors - Immunoblots or Allergy Tests - Cell, DNA, or Protein Arrays - Compound Handling In addition, BioDot developed modular workstations and enabled customers to work in either a "Batch" or "In-Line" Approach, depending on their materials and processes, as well as short and long goals. Now, in our 25th year, BioDot continues to be a leading supplier of system tools for the research, development and commercialization of diagnostic tests. With our continuously expanding product portfolio, BioDot has marketed systems for the development and manufacture of Microfluidics. We also have systems for the Life Sciences and the Molecular & Point of Care Diagnostics. By expanding our global presence with entities in China and the UK/Europe, BioDot has a commitment to fully understand our customer's requirements, globally. #lateralflow, #biosensor, #labonachip, #biochip, #dispensing